Advertisement

Index by author

April 01, 1998; Volume 285,Issue 1

  1. Ali, Fadia E.

    1. Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to Purified Integrin αIIbβ3: Evidence for a Common Binding Site for Cyclic Arginyl-Glycinyl-Aspartic Acid Peptides and Nonpeptides
      Angela Wong, Shing Mei Hwang, Kyung Johanson, James Samanen, Donald Bennett, Scott W. Landvatter, Wenting Chen, J. Richard Heys, Fadia E. Ali, Thomas W. Ku, William Bondinell, Andrew J. Nichols, David A. Powers and Jeffrey M. Stadel
      Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 228-235;

  2. Altier, Nadège

    1. Dopamine Receptor Antagonists in the Nucleus Accumbens Attenuate Analgesia Induced by Ventral Tegmental Area Substance P or Morphine and by Nucleus Accumbens Amphetamine
      Nadège Altier and Jane Stewart
      Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 208-215;

  3. Arata, Naoko

    1. Chronopharmacology of Granulocyte Colony-Stimulating Factor in Mice
      Shigehiro Ohdo, Naoko Arata, Taku Furukubo, Eiji Yukawa, Shun Higuchi, Shigeyuki Nakano and Nobuya Ogawa
      Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 242-246;

  4. Ashby, Barrie

    1. Agonist-Induced Desensitization and Down-regulation of the HumanKappa Opioid Receptor Expressed in Chinese Hamster Ovary Cells
      Jinmin Zhu, Lai-Yi Luo, Guan-Fen Mao, Barrie Ashby and Lee-Yuan Liu-Chen
      Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 28-36;

  5. Ator, Nancy A.

    1. Zolpidem Physical Dependence Assessed Across Increasing Doses Under a Once-Daily Dosing Regimen in Baboons
      Elise M. Weerts, Nancy A. Ator, Doreen M. Grech and Roland R. Griffiths
      Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 41-53;

  6. Bardin, M.

    1. Is the Reduced Efficacy of Morphine in Diabetic Rats Caused by Alterations of Opiate Receptors or of Morphine Pharmacokinetics?
      C. Courteix, P. Bourget, F. Caussade, M. Bardin, F. Coudore, J. Fialip and A. Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 63-70;

  7. Baskin, Elizabeth P.

    1. Differential Atrial versus Ventricular Activities of Class III Potassium Channel Blockers
      Elizabeth P. Baskin and Joseph J. Lynch
      Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 135-142;

  8. Beaven, Michael A.

    1. Thapsigargin-Induced Secretion Is Dependent on Activation of a Cholera Toxin-Sensitive and Phosphatidylinositol-3-kinase-Regulated Phospholipase D in a Mast Cell Line
      David S. Cissel, Paul F. Fraundorfer and Michael A. Beaven
      Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 110-118;

  9. Benishin, Christina G.

    1. Nitric Oxide Selectively Inhibits Intracellular Ca++Release Elicited by Inositol Trisphosphate but not Caffeine in Rat Vascular Smooth Muscle
      Junzhi Ji, Christina G. Benishin and Peter K. T. Pang
      Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 16-21;

  10. Bennett, Donald

    1. Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to Purified Integrin αIIbβ3: Evidence for a Common Binding Site for Cyclic Arginyl-Glycinyl-Aspartic Acid Peptides and Nonpeptides
      Angela Wong, Shing Mei Hwang, Kyung Johanson, James Samanen, Donald Bennett, Scott W. Landvatter, Wenting Chen, J. Richard Heys, Fadia E. Ali, Thomas W. Ku, William Bondinell, Andrew J. Nichols, David A. Powers and Jeffrey M. Stadel
      Journal of Pharmacology and Experimental Therapeutics April 1998, 285 (1) 228-235;
« Previous (Pages : 1 2 3 4 5 6 ... 24) Next »
Back to top

In this issue

Advertisement